GlycoMimetics, Inc.
GLYC
$0.25
-$0.0247-8.99%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.22M | -9.82M | -10.10M | -10.74M | -9.08M |
| Total Depreciation and Amortization | 0.00 | 8.10K | 12.40K | 14.60K | 23.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.13M | 1.64M | 1.42M | 1.40M | 1.14M |
| Change in Net Operating Assets | 2.39M | 182.80K | -231.10K | -1.18M | 299.90K |
| Cash from Operations | -3.70M | -7.99M | -8.89M | -10.51M | -7.62M |
| Capital Expenditure | 0.00 | 0.00 | -2.50K | -7.40K | -800.00 |
| Sale of Property, Plant, and Equipment | 30.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 30.00K | 0.00 | -2.50K | -7.40K | -800.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 500.00 | 4.90K | 1.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 0.00 | 500.00 | 4.90K | 1.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.67M | -7.99M | -8.90M | -10.51M | -7.61M |